90
Participants
Start Date
November 1, 2020
Primary Completion Date
February 28, 2021
Study Completion Date
February 28, 2021
Serratus anterior block (SAB)
Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5%
Erector spinae block
Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5%
Saline (as a placebo)
Patients will receive a sham block with 20 ml saline (as a placebo)
Bupivacaine
bupivacaine
National Cancer Institute, Cairo
National Cancer Institute, Egypt
OTHER